Glucocorticoids increase CD4+CD25high cell percentage and Foxp3 expression in patients with multiple sclerosis

被引:75
作者
Braitch, M.
Harikrishnan, S.
Robins, R. A. [1 ]
Nichols, C. [2 ]
Fahey, A. J.
Showe, L. [2 ]
Constantinescu, C. S.
机构
[1] Univ Nottingham, Sch Mol Med Sci, Div Immunol, Nottingham NG7 2UH, England
[2] Wistar Inst Anat & Biol, Syst Biol Div, Genom Core, Philadelphia, PA 19104 USA
来源
ACTA NEUROLOGICA SCANDINAVICA | 2009年 / 119卷 / 04期
关键词
CD25; cytokines; Foxp3; glucocorticoids; methylprednisolone; multiple sclerosis; regulatory T cells; REGULATORY T-CELLS; IMMUNOLOGICAL SELF-TOLERANCE; GENE-EXPRESSION; DENDRITIC CELLS; METHYLPREDNISOLONE; RECEPTOR; SUPPRESSION; MECHANISM; THERAPY; RELAPSE;
D O I
10.1111/j.1600-0404.2008.01090.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To determine whether percentages of CD4(+)CD25(high) T cells (a group of regulatory T cells, Treg) differ in patients with multiple sclerosis (MS) in relapse vs remission after glucocorticoid treatment and whether treatment for relapses changes Treg population and the expression of Foxp3, a key Treg-associated molecule. Peripheral blood mononuclear cells (PBMC) were obtained from 20 patients with MS during relapse, just before and 2 days after starting steroid treatment (i.v. methylprednisolone 1 g/day for 3 days) and then 6 weeks after treatment. CD4(+)CD25(hi) cells were analysed by using flow cytometry. Cytokines were measured by using an ELISA and Foxp3, CD3 and CD25 expression by using quantitative real-time PCR. The percentage of CD4(+)CD25(hi) cells, plasma IL-10 and Foxp3/CD3 ratio increased 48 h after methylprednisolone initiation and returned to baseline values by 6 weeks post-treatment. Results suggest that glucocorticoids increase Treg cell functional molecules and percentages. This may be a mechanism whereby steroids expedite recovery from MS relapses.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 31 条
[1]   Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells [J].
Bettelli, E ;
Dastrange, M ;
Oukka, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (14) :5138-5143
[2]   Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death [J].
Chen, X ;
Murakami, T ;
Oppenheim, JJ ;
Howard, DMZ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) :859-869
[3]   Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cells in vivo and enhances their capacity to suppress EAE [J].
Chen, Xin ;
Oppenheim, Joost J. ;
Winkler-Pickett, Robin T. ;
Ortaldo, John R. ;
Howard, O. M. Zack .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (08) :2139-2149
[4]   Avonex Combination Trial in relapsing-remitting MS: rationale, design and baseline data [J].
Cohen, J. A. ;
Calabresi, P. A. ;
Chakraborty, S. ;
Edwards, K. R. ;
Eickenhorst, T. ;
Felton, W. L., III ;
Fisher, E. ;
Fox, R. J. ;
Goodman, A. D. ;
Hara-Cleaver, C. ;
Hutton, G. J. ;
Imrey, P. B. ;
Ivancic, D. M. ;
Mandell, B. F. ;
Perryman, J. E. ;
Scott, T. F. ;
Skaramagas, T. T. ;
Zhang, H. .
MULTIPLE SCLEROSIS, 2008, 14 (03) :370-382
[5]   Interferon beta-1a therapy enhances CD4+ regulatory T-cell function:: An ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis [J].
de Andres, Clara ;
Aristimuno, Carol ;
de las Heras, Virginia ;
Martinez-Gines, M. Luisa ;
Bartolome, Manuel ;
Arroyo, Rafael ;
Navarro, Joaquin ;
Gimenez-Roldan, Santiago ;
Fernandez-Cruz, Eduardo ;
Sanchez-Ramon, Silvia .
JOURNAL OF NEUROIMMUNOLOGY, 2007, 182 (1-2) :204-211
[6]  
de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771
[7]   A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability [J].
Dhawan, Latika ;
Liu, Bin ;
Blaxall, Burns C. ;
Taubman, Mark B. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (14) :10146-10152
[8]   Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma [J].
El-Radhi, AS ;
Hogg, CL ;
Bungre, JK ;
Bush, A ;
Corrigan, CJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 2000, 83 (02) :158-162
[9]   Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation [J].
Elovaara, I ;
Kuusisto, H ;
Paalavuo, R ;
Särkijärvi, S ;
Lehtimäki, T ;
Huhtala, H ;
Vilpo, J .
ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 (03) :163-166
[10]   Effects of glucocorticoids on STAT4 activation in human T cells are stimulus-dependent [J].
Fahey, Angela J. ;
Robins, R. Adrian ;
Kindle, Karin B. ;
Heery, David M. ;
Constantinescu, Cris S. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 80 (01) :133-144